Jeff Castelli Amicus Therapeutics, Inc. (FOLD) insider trading activity

Jeff Castelli is Chief Development Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 465,476 shares of FOLD, which is worth approximately $4.25 Million. The most recent transaction as insider was on Feb 11, 2025, when has been sold 22,724 shares (Common Stock) at a price of $9.57 per share, resulting in proceeds of $217,468. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 465K

28.3% 3M change

28.3% 12M change

Total Value Held $4.25 Million

Jeff Castelli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	SELL Payment of exercise price or tax liability	$217,468 $9.57 p/Share	22,724 Reduced 4.65%	465,476 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	52,338 Added 9.68%	488,200 Common Stock
Jan 04 2025	SELL Payment of exercise price or tax liability	$29,425 $9.41 p/Share	3,127 Reduced 0.71%	435,862 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$134,553 $9.41 p/Share	14,299 Reduced 3.15%	438,989 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	83,073 Added 15.49%	453,288 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$65,076 $9.31 p/Share	6,990 Reduced 1.85%	370,215 Common Stock
Jan 09 2024	SELL Payment of exercise price or tax liability	$136,568 $13.65 p/Share	10,005 Reduced 2.68%	362,800 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$42,026 $13.44 p/Share	3,127 Reduced 0.83%	372,805 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$190,542 $13.53 p/Share	14,083 Reduced 3.61%	375,932 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$114,461 $14.24 p/Share	8,038 Reduced 2.02%	390,015 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	57,392 Added 12.6%	398,053 Common Stock
Dec 28 2023	SELL Open market or private sale	$252,952 $14.52 p/Share	17,421 Reduced 4.87%	340,661 Common Stock
Dec 20 2023	SELL Open market or private sale	$21,667 $13.1 p/Share	1,654 Reduced 0.46%	358,082 Common Stock
Dec 19 2023	SELL Open market or private sale	$231,875 $13.25 p/Share	17,500 Reduced 4.64%	359,736 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	-	8,643 Added 2.24%	377,236 Common Stock
Aug 17 2023	SELL Payment of exercise price or tax liability	$185,931 $12.77 p/Share	14,560 Reduced 3.8%	368,593 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$292,386 $12.02 p/Share	24,325 Reduced 5.97%	383,153 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	56,024 Added 12.09%	407,478 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$37,617 $12.03 p/Share	3,127 Reduced 0.88%	351,454 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$76,483 $11.93 p/Share	6,411 Reduced 1.78%	354,581 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	70,681 Added 16.37%	360,992 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$170,256 $12.21 p/Share	13,944 Reduced 4.58%	290,311 Common Stock

Jeff Castelli

Chief Development Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account